Author's reply: "Early surgery for Crohn's disease-An appeal for a reassessment of biologics"
Dig Liver Dis
.
2023 Dec;55(12):1777-1778.
doi: 10.1016/j.dld.2023.09.005.
Epub 2023 Oct 22.
Authors
Nicolás Avellaneda
1
,
Paulo Gustavo Kotze
2
;
Surgical IBD LATAM Consortium
Affiliations
1
General Surgery Department, Hospital Universitario CEMIC, Galván 4102, Caba C1431, Argentina; Colorectal Surgery Department, Aarhus University Hospital, Palle Juul-Jensens Blvd. 161, Aarhus 8200, Denmark. Electronic address: n.avellaneda86@gmail.com.
2
Colorectal Surgery Unit, Pontificia Universidade Católica do Paraná (PUCPR), R. Imac. Conceição, 1155-Prado Velho, 80215-901 Curitiba-PR, Brazil.
PMID:
37872074
DOI:
10.1016/j.dld.2023.09.005
No abstract available
Publication types
Letter
MeSH terms
Biological Products* / therapeutic use
Crohn Disease* / drug therapy
Crohn Disease* / surgery
Humans
Substances
Biological Products